Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
Colorado State University
Zagazig University
Carevive Systems, Inc.
Essen Biotech
Ohio State University Comprehensive Cancer Center
Mayo Clinic
AC Camargo Cancer Center
Incyte Corporation
M.D. Anderson Cancer Center
University of Colorado, Denver
Arab American University (Palestine)
Washington University School of Medicine
University of Alabama at Birmingham
Baxter Healthcare Corporation
Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León
Cedars-Sinai Medical Center
Universidade Federal de Pernambuco
Cyteir Therapeutics, Inc.
Cedars-Sinai Medical Center
OHSU Knight Cancer Institute
Incyte Corporation
Scripps Health
Novartis
Jonsson Comprehensive Cancer Center
Celgene
InSightec
University of Wisconsin, Madison
AbbVie
City of Hope Medical Center
Incyte Corporation
The Christie NHS Foundation Trust
Alliance for Clinical Trials in Oncology
Amgen
Wake Forest University Health Sciences
Stanford University
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Alliance for Clinical Trials in Oncology
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
University of Louisville
Fred Hutchinson Cancer Center
Novartis
Rutgers, The State University of New Jersey
Shenzhen Second People's Hospital
Alliance for Clinical Trials in Oncology